PRIME: PReservIng Memory in Epilepsy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

PRIME: PReservIng Memory in Epilepsy — Stella

Home/Mesial Temporal Lobe Epilepsy/

View on ClinicalTrials.gov

Recruiting

Back to Mesial Temporal Lobe Epilepsy trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

United States

Mayo Clinic, Rochester, Minnesota

The University of Texas Science Center at Houston, Houston, Texas

Key details

Sponsor

Nitin Tandon

Collaborators

National Institute of Neurological Disorders and Stroke (NINDS)

Enrollment target

~8 participants

Started

November 2023

Primary completion

March 2028

Age range

18 Years – 65 Years

Last updated December 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.